Pacira BioSciences, Inc. (PCRX) Insider Ownership

Historic Insider Ownership Trends

According to recent filings covering the 90 days ending February 19, 2026, the three most significant insider holders at Pacira BioSciences are Chief Executive Officer Frank D. Lee (660.83K shares), Chief Medical Officer Jonathan Slonin (226.90K shares), Ceo And Chairman David M Stack (186.48K shares).

Top Direct Holders

Insider ownership data is derived from the last 60 months of Form 4 SEC filings.
Holder Position Shares Report Date
Frank D. Lee Chief Executive Officer 660,831 13 Feb, 2026
Jonathan Slonin Chief Medical Officer 226,901 13 Feb, 2026
David M Stack Ceo And Chairman 186,481 16 Jun, 2023
Kristen Williams Chief Administrative Officer 185,849 13 Feb, 2026
Daryl Gaugler Chief Operating Officer 115,443 06 Jan, 2025
Shawn Cross Chief Financial Officer 105,341 13 Feb, 2026
Brendan Teehan Chief Commercial Officer 100,934 13 Feb, 2026
Lauren Riker Senior Vice President And Finance 71,586 13 Feb, 2026
Roy Winston Chief Medical Officer 52,440 04 Aug, 2023
Charles A. Iii Reinhart Chief Financial Officer 51,867 13 Jun, 2024
Charles Anthony Laranjeira Chief Technical Officer 41,752 16 Jun, 2022
Dennis Mcloughlin Chief Customer Officer 38,115 07 Jun, 2023
Mark A. Kronenfeld 34,901 13 Jun, 2025
Ronald J. Jr. Ellis Chief Strategy Officer 30,909 07 Jun, 2023
Donald C. Manning Chief Medical Officer 29,520 11 Jun, 2021
Max Reinhardt President And Rest Of World 29,225 07 Jun, 2023
Laura Brege 23,715 13 Jun, 2025
Gary W Pace 22,127 08 Mar, 2024
Mark Froimson 20,636 13 Jun, 2025
John P Phd Longenecker 18,823 07 Mar, 2022
Christopher Christie 16,654 13 Jun, 2025
Michael J. Yang 13,393 13 Jun, 2025
Yvonne Greenstreet 13,247 08 Jun, 2022
Anthony Molloy Chief Lgl & Compliance Officer 12,877 07 Jun, 2023
Paul J Hastings 12,724 13 Jun, 2024
Marcelo Bigal 11,393 11 Aug, 2025
Alethia Young 11,393 13 Jun, 2025
Abraham Ceesay 9,039 08 Sep, 2025

* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.

Recent Insider Transactions

Detailed insider trading activity based on Form 4 SEC filings.
Download Data
Transaction Date Insider Name Security Class Transaction Type Shares Traded Price Shares Remaining Ownership Code
11 Feb, 2026 Kristen Williams Common Stock A 54,546 $0.00 185,849 D A
11 Feb, 2026 Lauren Riker Common Stock A 19,273 $0.00 71,586 D A
11 Feb, 2026 Shawn Cross Common Stock A 49,091 $0.00 105,341 D A
11 Feb, 2026 Frank D. Lee Common Stock A 261,818 $0.00 660,831 D A
11 Feb, 2026 Jonathan Slonin Common Stock A 54,546 $0.00 226,901 D A
11 Feb, 2026 Brendan Teehan Common Stock A 51,714 $0.00 100,934 D A
02 Feb, 2026 Kristen Williams Common Stock D 13,137 $20.53 131,303 D S
02 Feb, 2026 Lauren Riker Common Stock D 4,000 $20.81 52,313 D S
30 Jan, 2026 Kristen Williams Common Stock D 17,134 $20.54 144,440 D F
30 Jan, 2026 Lauren Riker Common Stock D 2,751 $20.54 56,313 D F
30 Jan, 2026 Frank D. Lee Common Stock D 41,488 $20.54 399,013 D F
30 Jan, 2026 Jonathan Slonin Common Stock D 6,168 $20.54 172,355 D F
30 Jan, 2026 Brendan Teehan Common Stock D 5,182 $20.54 49,220 D F
05 Jan, 2026 Lauren Riker Common Stock D 1,416 $24.24 59,064 D S
02 Jan, 2026 Lauren Riker Common Stock D 159 $24.46 60,480 D F
02 Jan, 2026 Frank D. Lee Common Stock D 9,272 $24.46 440,501 D F
02 Jan, 2026 Jonathan Slonin Common Stock D 381 $24.46 178,523 D F
31 Dec, 2025 Brendan Teehan Common Stock A 402 $10.76 54,402 D A
10 Dec, 2025 Shawn Cross Common Stock A 9,104 $16.45 65,354 D M
10 Dec, 2025 Shawn Cross Common Stock D 9,104 $25.14 56,250 D S